Cours Evotec SE Other OTC
Actions
EVTCY
US30050E1055
Recherche biotechnologique et médicale
CA 2024 * | 875 M 947 M 866 M | CA 2025 * | 1,03 Md 1,11 Md 1,02 Md | Capitalisation | 1,7 Md 1,84 Md 1,69 Md |
---|---|---|---|---|---|
Résultat net 2024 * | -28 M -30,32 M -27,73 M | Résultat net 2025 * | 24 M 25,99 M 23,77 M | VE / CA 2024 * | 2,25 x |
Dette nette 2024 * | 269 M 291 M 266 M | Dette nette 2025 * | 235 M 254 M 233 M | VE / CA 2025 * | 1,89 x |
PER 2024 * |
-61,3
x | PER 2025 * |
36,6
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 90,64% |
Dernier transcript sur Evotec SE
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 07/02/23 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 01/05/12 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Roland Sackers
BRD | Director/Board Member | 56 | 19/06/19 |
Chairman | 63 | 17/06/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+64,23% | 62,59 Md | |
-2,31% | 41,18 Md | |
+44,36% | 40,29 Md | |
-8,29% | 27,9 Md | |
+11,97% | 26,21 Md | |
-21,16% | 19,09 Md | |
+7,54% | 13,08 Md | |
+27,17% | 12,05 Md | |
+25,72% | 12,26 Md |